Newsletter February 2018

//Newsletter February 2018

IPPOSI Prioritisation Survey

We are asking ALL MEMBERS to take part in our 2018 prioritization survey, which takes just five minutes to complete.  The survey provides you with a direct way to influence what IPPOSI will focus on, so we would be very grateful if you can complete it today.

Rare Disease Day 2018

IPPOSI will be in Belfast on Monday March 5th to celebrate another joint rare disease day with the NIRDP . You can still register here and we hope to see you there. Meanwhile, in case you missed it, there was an excellent profile piece of Professor Eileen Treacy in the January HRB newsletter. Professor Treacy is Clinical Lead for the National Clinical Programme for Rare Diseases.

#Actiononaccess

The European Commission recently launched proposals on Health Technology Assessment (HTA) in which it outlines mandatory use of joint clinical assessments reports, after a three-year transition period.  IPPOSI welcomes the EC plan and recently published this statement in response to the proposal.

EUPATI Webinar

IPPOSI’s Derick Mitchell is chairing a EUPATI webinar at 4pm GMT on March 15th 2018 concerning how to build stakeholder relationships at the national level. Over 100 people have registered already and all of the details – including speakers, topics etc. – are available here. As with all EUPATI webinars, you must register first before you can attend the webinar.

#Actiononaccess

IPPOSI recently launched our theme for 2018 – Access to Medicines (#actiononaccess) – which you can read about in detail on our dedicated website section here. This includes a number of key actions for the year, including the recently published  second Drug Iceberg Report, in partnership with the MRCG.

Gene Editing conference / Royal Irish Academy

As IPPOSI CEO, Derick Mitchell is a member of the Royal Irish Academy’s Life & Medical Sciences Committee.  Derick will chair a session during an upcoming RIA-hosted conference on April 26th on the ethical implications of Gene Editing Technologies (the CRISPR-Cas9 technique) for all of life and medical science. All details are available here, email info@ria.ie for tickets (minor cost involved).

HRB-TMRN – Study results

The HRB Trials Methodology Research Network has published the results from its PRioRiTy I study on the Top 10 unanswered questions relating to recruitment in randomized trials. The results are published here (with IPPOSI in the authorship). If you want to see the full list of questions, you can visit the project’s excellent website here.

IPPOSI Patient Education Programme

We are drawing near to the end of the Pilot Patient Education Programme and what a journey it has been! Patients, Carers, Students, Education Partners and numerous IPPOSI members have put in an enormous effort to promote patient education on clinical trials, regulatory affairs and health technology assessment. In so doing, their drive and enthusiasm has knocked the socks off everyone involved and we are really looking forward to the informal ‘graduation’ that will take place on March 12th. Expect plenty of photos from that event!

2018-03-01T16:38:32+01:00 1 March 2018|Newsletters|0 Comments
 

Related Posts

10 April 2019

Newsletter March 2019

Subscribe to IPPOSI News

Interested in receiving the IPPOSI newsletter and updates on events? Click the subscribe button